Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF-CAP) in China.

ABSTRACT:

Aims

Implementing optimal guideline-directed medical therapy is still challenging in patients with heart failure (HF). This prospective study assessed the benefits of large-scale, nationwide, multi-annual implementation of HF therapies in China.

Methods and results

This longitudinal, pre-post comparison design included patients in hospitals accredited by the National Heart Failure Center Accreditation Program (HF-CAP). Patients were divided into four groups: 6-12 months before accreditation (Pre); >0 -≤12 months after accreditation (Y1); >12-≤24 months after accreditation (Y2), and >24 months after accreditation (Y2+). The primary endpoint was 1-year composite HF readmission and/or cardiovascular death. Secondary endpoints included 1-year HF readmission alone, 1-year cardiov

SUBMITTER: Zhou J 

PROVIDER: S-EPMC12765234 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature